Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT05076682RecruitingTriple-negative Breast Cancer
-
NCT04886531RecruitingBreast Cancer | HER2-positive Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer
-
NCT04192903RecruitingTriple-negative Breast Cancer
-
NCT06382142Active, not recruiting
-
NCT03328026CompletedBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer Metastatic
-
NCT02755272Active, not recruiting
-
NCT05336721TerminatedTriple-negative Breast Cancer
-
NCT03639948Active, not recruitingTriple-negative Breast Cancer
-
NCT04177108Completed
-
NCT02101385CompletedBreast Cancer | Malignant Neoplasm of Breast
-
-
NCT04584112Completed
-
NCT02427581WithdrawnTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer
-
NCT04750382Active, not recruitingTriple-negative Breast Cancer
-
NCT02348320CompletedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer
-
NCT03202446TerminatedBreast Cancer Stage IV | Breast Cancer Stage IIIA | Breast Cancer, Stage IIIB
-
NCT01361945WithdrawnBreast Cancer | Metastatic Breast Cancer | HER-2 Positive Breast Cancer | ER Positive Breast Cancer
-
NCT00393341CompletedQuantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer (EPC)Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage II
-
NCT00146588CompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer
-
NCT02883062Active, not recruitingInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7
-
NCT05660083RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Metaplastic Breast Carcinoma
-
-
NCT01753908CompletedInvasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | Lobular Breast Carcinoma | Postmenopausal | Ductal Breast Carcinoma
-
NCT04715802Active, not recruitingBreast Reconstruction | Mammaplasty | Breast
-
NCT06768931RecruitingBreast Cancer | Early Stage Breast Cancer | Immunotherapy | Triple Negative Breast Cancer (TNBC) | Probiotic
-
NCT01277757CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer
-
NCT00096109TerminatedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
NCT01409811TerminatedStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Invasive Ductal Breast Carcinoma
-
NCT02125344CompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III
-
NCT07299409Not yet recruitingBreast Cancer | Breast Cancer Metastatic | Advanced Triple Negative Breast Cancer
-
NCT07217990Not yet recruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer
-
NCT05720260RecruitingMetastatic Breast Cancer | Premenopausal Breast Cancer | ER Positive Breast Cancer
-
-
NCT03164993CompletedTriple Negative Breast Cancer | Cancer, Breast
-
NCT05227131WithdrawnAdvanced Breast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer
-
NCT01885741CompletedBreast Cancer Screening | Breast Cancer Diagnosis | MRI Guided Breast Biopsy
-
NCT07276880RecruitingBreast Cancer | Triple Negative Breast Cancer (TNBC) | Node-positive Breast Cancer | HER2-Negative Breast Carcinoma
-
NCT07085767RecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast Cancer
-
NCT06064812RecruitingMetastatic Breast Cancer | Breast Cancer Stage IV | Locally Advanced Breast Cancer | ER+/HER2- Breast Cancer
-
NCT05535192RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Stage III Breast Cancer
-
NCT02316457CompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))
-
NCT06386263CompletedMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast Cancer
-
NCT04123704TerminatedBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer Metastatic
-
NCT03112590CompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer Female
-
NCT01194427TerminatedStage I Breast Cancer | Invasive Breast Cancer | Stage II Breast Cancer | Stage III Breast Cancer
-
NCT06744465RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Carcinoma | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer
-
NCT03981705CompletedTriple Negative Breast Cancer | HER2-positive Breast Cancer | TN ER-/PR-/HER2- Breast Cancer | ERany/PRany/HER2+ Breast Cancer
-
NCT00082810CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer
-
NCT07073755RecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Drug Resistance | Treatment Decisions | Hormone Receptor-Positive Breast Cancer | Triple-Negative Breast Cancer (TNBC)
-
NCT01776008TerminatedRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative
-
NCT07483307RecruitingBreast Cancer | HER2-negative Breast Cancer | ER+ Breast Cancer | HER2 Negative Breast Carcinoma
-
NCT06691035RecruitingHER2-negative Breast Cancer | Breast Cancer Metastatic Breast Cancer